Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,217,193 papers from all fields of science
Search
Sign In
Create Free Account
Topotecan 4 MG Injection
Known as:
topotecan (as topotecan hydrochloride) 4 MG Injection
, TOPOTECAN HYDROCHLORIDE 4 mg in 4 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Topotecan Hydrochloride]
, TOPOTECAN HCL 4MG/VIL INJ
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Carcinoma, Small Cell
Hydrochloric Acid
Injection
Lactation
Expand
Narrower (1)
Topotecan 4 MG Injection [Hycamtin]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Long-Term Follow-Up Results of the Combination of Topotecan and Cytarabine and Other Intensive Chemotherapy Regimens in Myelodysplastic Syndrome.
E. Jabbour
,
H. Kantarjian
,
+8 authors
E. Estey
2005
Corpus ID: 224658472
Background. Higher-risk myelodysplastic syndrome (MDS) is often treated with intensive chemotherapy regimens used for acute…
Expand
2002
2002
Combined Effect of Topotecan and Irradiation on the Survival and the Induction of Chromosome Aberrations in Vitro
M. Rave-Fränk
,
Sabine Glomme
,
+5 authors
H. Schmidberger
Strahlentherapie und Onkologie (Print)
2002
Corpus ID: 35227614
Background: Topotecan demonstrated radiosensitizing effects in vivo and in vitro, which are schedule- and cell line department…
Expand
Review
2000
Review
2000
2nd-line-Chemotherapie nach Platin- oder Platin-Paclitaxel-haltiger Primärtherapie beim Ovarialkarzinom: eine systematische Übersicht der publizierten Daten bis 1998
A. Bois
,
H. Lück
,
T. Bauknecht
2000
Corpus ID: 72601477
Trotz der in den letzten Jahrzehnten erreichten Fortschritte in der Primarbehandlung des fortgeschrittenen Ovarialkarzinoms…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required